Company Filing History:
Years Active: 2006
Title: The Innovative Contributions of Yukio Sumi
Introduction: Yukio Sumi is a notable inventor based in Nagoya, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the area of wound healing. His innovative work has led to the development of a unique formulation aimed at inhibiting wound contraction.
Latest Patents: Yukio Sumi holds a patent for a pharmaceutical formulation designed to inhibit wound contraction. This formulation includes secretory leukocyte protease inhibitor (SLPI) as its active ingredient. The optimal concentration of SLPI in the formulation ranges from 1 to 5000 ng/ml, with a more preferred concentration between 1 to 100 ng/ml. The formulation can be prepared as an external preparation or as an injection, both of which may include additional components such as preservatives and stabilizers.
Career Highlights: Sumi is associated with Japan Tissue Engineering Co., Ltd., where he continues to advance his research and development efforts. His work has been instrumental in creating effective solutions for wound management, showcasing his dedication to improving patient care.
Collaborations: Throughout his career, Yukio Sumi has collaborated with esteemed colleagues, including Kenichiro Hata and Minoru Ueda. These partnerships have fostered a collaborative environment that enhances innovation and research in the field.
Conclusion: Yukio Sumi's contributions to pharmaceutical formulations for wound healing exemplify the impact of innovative thinking in medicine. His patent and ongoing work continue to pave the way for advancements in wound care.